In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.

Author: , Beilstein-WedelErin, BrownDerek W, BrummelSean S, ChadwickEllen G, ChanockStephen J, EngelsEric A, HartleyStephen W, HazraRohan, KacanekDeborah, KaryadiDanielle M, LeeOlivia W, LinShu-Hong, MachielaMitchell J, MarsitCarmen J, PoirierMiriam C, WangYoujin, ZhouWeiyin, ZhuBin

Paper Details 
Original Abstract of the Article :
OBJECTIVE: Zidovudine (ZDV) has been extensively used in pregnant women to prevent vertical transmission of HIV but few studies have evaluated potential mutagenic effects of ZDV during fetal development. DESIGN: Our study investigated clonal hematopoiesis in HIV-exposed uninfected (HEU) newborns, 9...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/33756513

データ提供:米国国立医学図書館(NLM)

Investigating the Impact of Zidovudine on Fetal Development

This research delves into a crucial area of [pediatric health] - exploring the potential long-term effects of [antiretroviral therapy] during fetal development. The study, a [cohort study], aimed to investigate [clonal hematopoiesis] in [HIV-exposed uninfected newborns] who were exposed to [zidovudine] in utero. Researchers utilized [high-depth sequencing and genotyping arrays] to analyze blood samples collected from these newborns, comparing them to a control group of [ART-unexposed newborns].

No Statistically Significant Impact of Zidovudine on Clonal Hematopoiesis

The findings of this study, like a cool oasis in the desert, provided a sense of relief – no statistically significant difference was observed in the number of [SNVs and indels] between the groups. This suggests that [in-utero ZDV exposure] may not have a strong impact on [clonal hematopoiesis] at the levels detectable in this study. However, the authors emphasize the need for further investigation, particularly concerning the long-term implications of [in-utero ZDV exposure] and the possibility of genomic aberrations occurring later in pregnancy.

Implications for Future Research and Patient Care

While the study provides reassuring insights, it is crucial to recognize that [long-term effects] of [in-utero ZDV exposure] may manifest later in life. Like the shifting sands of the desert, the long-term consequences of [in-utero ZDV exposure] require continuous monitoring and research. This study encourages additional follow-up studies to ensure the safety of [ZDV] and its potential impacts on [HEU children].

Dr.Camel's Conclusion

While this study suggests that Zidovudine exposure in utero may not have a significant impact on clonal hematopoiesis in newborns, the need for continued monitoring and research is crucial to ensure the long-term health and safety of these children. It’s like navigating a vast and unknown desert – with each step, we gain new insights into the complexities of fetal development and the potential long-term effects of medications.

Date :
  1. Date Completed 2021-08-06
  2. Date Revised 2023-09-21
Further Info :

Pubmed ID

33756513

DOI: Digital Object Identifier

NIHMS1685556

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.